{"entity":{"type":"insider","cik":"0001298034","url":"/insider/0001298034","json_url":"/insider/0001298034.json","name":"DP VI Associates, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":49,"n_filings":29,"first":"2006-09-20","last":"2016-08-03","span_basis":"filed_date"},"name_variants":[{"name":"DP VI Associates, L.P.","source":"filing","n_filings":29,"first_seen":"2006-09-20","last_seen":"2016-08-03"}],"transactions":[{"id":2268817,"accession":"0000904454-16-001354","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-16-001354","line_url":"/filing/0000904454-16-001354#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; DOVEY BRIAN H; DP VI Associates, L.P.; BLAIR JAMES C; VITULLO NICOLE","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":129.0,"shares_display":"129","price_per_share":8.15,"price_display":"8.15","price_state":"stated","total_value":1051.35,"total_display":"1,051.35","total_whole":"1,051","shares_owned_after":3039.0,"shares_owned_after_display":"3,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-03","filed_date":"2016-08-03","scope":"insider"},{"id":2268814,"accession":"0000904454-16-001354","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001354","line_url":"/filing/0000904454-16-001354#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; DOVEY BRIAN H; DP VI Associates, L.P.; BLAIR JAMES C; VITULLO NICOLE","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32.0,"shares_display":"32","price_per_share":8.71,"price_display":"8.71","price_state":"stated","total_value":278.72,"total_display":"278.72","total_whole":"279","shares_owned_after":3168.0,"shares_owned_after_display":"3,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-02","filed_date":"2016-08-03","scope":"insider"},{"id":2268811,"accession":"0000904454-16-001354","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001354","line_url":"/filing/0000904454-16-001354#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; DOVEY BRIAN H; DP VI Associates, L.P.; BLAIR JAMES C; VITULLO NICOLE","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84.0,"shares_display":"84","price_per_share":8.82,"price_display":"8.82","price_state":"stated","total_value":740.88,"total_display":"740.88","total_whole":"741","shares_owned_after":3200.0,"shares_owned_after_display":"3,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-01","filed_date":"2016-08-03","scope":"insider"},{"id":2989140,"accession":"0000904454-16-001194","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001194","line_url":"/filing/0000904454-16-001194#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DP VI Associates, L.P.; DOVEY BRIAN H; TREU JESSE I; BLAIR JAMES C; VITULLO NICOLE","owner_display_name":"DP VI Associates, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":235.0,"shares_display":"235","price_per_share":6.96,"price_display":"6.96","price_state":"stated","total_value":1635.6,"total_display":"1,635.60","total_whole":"1,636","shares_owned_after":3284.0,"shares_owned_after_display":"3,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-28","filed_date":"2016-05-02","scope":"insider"},{"id":6173273,"accession":"0000904454-14-000081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-14-000081","line_url":"/filing/0000904454-14-000081#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; TREU JESSE I; DP VI Associates, L.P.; BLAIR JAMES C; VITULLO NICOLE","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2230.0,"shares_display":"2,230","price_per_share":6.56,"price_display":"6.56","price_state":"stated","total_value":14628.8,"total_display":"14,628.80","total_whole":"14,629","shares_owned_after":34907.0,"shares_owned_after_display":"34,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-16","filed_date":"2014-01-17","scope":"insider"},{"id":6173270,"accession":"0000904454-14-000081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-14-000081","line_url":"/filing/0000904454-14-000081#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; TREU JESSE I; DP VI Associates, L.P.; BLAIR JAMES C; VITULLO NICOLE","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1010.0,"shares_display":"1,010","price_per_share":6.01,"price_display":"6.01","price_state":"stated","total_value":6070.1,"total_display":"6,070.10","total_whole":"6,070","shares_owned_after":37137.0,"shares_owned_after_display":"37,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-15","filed_date":"2014-01-17","scope":"insider"},{"id":5494931,"accession":"0000904454-13-000717","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000717","line_url":"/filing/0000904454-13-000717#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; VITULLO NICOLE; TREU JESSE I; BLAIR JAMES C; DOVEY BRIAN H; DP VI Associates, L.P.","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":114.0,"shares_display":"114","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":571.14,"total_display":"571.14","total_whole":"571","shares_owned_after":38147.0,"shares_owned_after_display":"38,147","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-20","filed_date":"2013-06-24","scope":"insider"},{"id":5349982,"accession":"0000904454-13-000713","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000713","line_url":"/filing/0000904454-13-000713#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DP VI Associates, L.P.; DOVEY BRIAN H; TREU JESSE I; SCHOEMAKER KATHLEEN K; BLAIR JAMES C; VITULLO NICOLE","owner_display_name":"DP VI Associates, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":244.0,"shares_display":"244","price_per_share":5.37,"price_display":"5.37","price_state":"stated","total_value":1310.28,"total_display":"1,310.28","total_whole":"1,310","shares_owned_after":38261.0,"shares_owned_after_display":"38,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-19","filed_date":"2013-06-20","scope":"insider"},{"id":5349977,"accession":"0000904454-13-000713","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000713","line_url":"/filing/0000904454-13-000713#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DP VI Associates, L.P.; DOVEY BRIAN H; TREU JESSE I; SCHOEMAKER KATHLEEN K; BLAIR JAMES C; VITULLO NICOLE","owner_display_name":"DP VI Associates, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":359.0,"shares_display":"359","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":1938.6,"total_display":"1,938.60","total_whole":"1,939","shares_owned_after":38505.0,"shares_owned_after_display":"38,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-18","filed_date":"2013-06-20","scope":"insider"},{"id":4275524,"accession":"0000904454-13-000703","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000703","line_url":"/filing/0000904454-13-000703#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; BLAIR JAMES C; VITULLO NICOLE; DP VI Associates, L.P.","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":959.0,"shares_display":"959","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":5178.6,"total_display":"5,178.60","total_whole":"5,179","shares_owned_after":38864.0,"shares_owned_after_display":"38,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-17","filed_date":"2013-06-18","scope":"insider"},{"id":4275520,"accession":"0000904454-13-000703","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000703","line_url":"/filing/0000904454-13-000703#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; BLAIR JAMES C; VITULLO NICOLE; DP VI Associates, L.P.","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":425.0,"shares_display":"425","price_per_share":5.03,"price_display":"5.03","price_state":"stated","total_value":2137.75,"total_display":"2,137.75","total_whole":"2,138","shares_owned_after":39823.0,"shares_owned_after_display":"39,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-14","filed_date":"2013-06-18","scope":"insider"},{"id":5095899,"accession":"0000904454-13-000691","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000691","line_url":"/filing/0000904454-13-000691#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; DP VI Associates, L.P.; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; BLAIR JAMES C; VITULLO NICOLE","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59.0,"shares_display":"59","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":295.0,"total_display":"295.00","total_whole":"295","shares_owned_after":40248.0,"shares_owned_after_display":"40,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-11","filed_date":"2013-06-13","scope":"insider"},{"id":4572969,"accession":"0000904454-13-000584","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000584","line_url":"/filing/0000904454-13-000584#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; DP VI Associates, L.P.; VITULLO NICOLE; BLAIR JAMES C; TREU JESSE I; SCHOEMAKER KATHLEEN K","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":232.0,"shares_display":"232","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":1044.0,"total_display":"1,044.00","total_whole":"1,044","shares_owned_after":40307.0,"shares_owned_after_display":"40,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-16","filed_date":"2013-05-17","scope":"insider"},{"id":4572964,"accession":"0000904454-13-000584","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000584","line_url":"/filing/0000904454-13-000584#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; DP VI Associates, L.P.; VITULLO NICOLE; BLAIR JAMES C; TREU JESSE I; SCHOEMAKER KATHLEEN K","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":251.0,"shares_display":"251","price_per_share":4.7,"price_display":"4.70","price_state":"stated","total_value":1179.7,"total_display":"1,179.70","total_whole":"1,180","shares_owned_after":40539.0,"shares_owned_after_display":"40,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-15","filed_date":"2013-05-17","scope":"insider"},{"id":4431099,"accession":"0000904454-13-000469","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000469","line_url":"/filing/0000904454-13-000469#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; TREU JESSE I; DOVEY BRIAN H; BLAIR JAMES C; SCHOEMAKER KATHLEEN K; DP VI Associates, L.P.","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1743.0,"shares_display":"1,743","price_per_share":5.49,"price_display":"5.49","price_state":"stated","total_value":9569.07,"total_display":"9,569.07","total_whole":"9,569","shares_owned_after":78369.0,"shares_owned_after_display":"78,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-21","filed_date":"2013-03-22","scope":"insider"},{"id":5002437,"accession":"0000904454-13-000461","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000461","line_url":"/filing/0000904454-13-000461#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DP VI Associates, L.P.; DOVEY BRIAN H; BLAIR JAMES C; VITULLO NICOLE; SCHOEMAKER KATHLEEN K; TREU JESSE I","owner_display_name":"DP VI Associates, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":182.0,"shares_display":"182","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":950.04,"total_display":"950.04","total_whole":"950","shares_owned_after":80112.0,"shares_owned_after_display":"80,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-20","filed_date":"2013-03-21","scope":"insider"},{"id":5002432,"accession":"0000904454-13-000461","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000461","line_url":"/filing/0000904454-13-000461#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DP VI Associates, L.P.; DOVEY BRIAN H; BLAIR JAMES C; VITULLO NICOLE; SCHOEMAKER KATHLEEN K; TREU JESSE I","owner_display_name":"DP VI Associates, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":261.0,"shares_display":"261","price_per_share":5.19,"price_display":"5.19","price_state":"stated","total_value":1354.59,"total_display":"1,354.59","total_whole":"1,355","shares_owned_after":80294.0,"shares_owned_after_display":"80,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-19","filed_date":"2013-03-21","scope":"insider"},{"id":5048501,"accession":"0000904454-13-000451","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000451","line_url":"/filing/0000904454-13-000451#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; BLAIR JAMES C; TREU JESSE I; DP VI Associates, L.P.; VITULLO NICOLE; DOVEY BRIAN H","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":265.0,"shares_display":"265","price_per_share":5.16,"price_display":"5.16","price_state":"stated","total_value":1367.4,"total_display":"1,367.40","total_whole":"1,367","shares_owned_after":80555.0,"shares_owned_after_display":"80,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-18","filed_date":"2013-03-19","scope":"insider"},{"id":5048497,"accession":"0000904454-13-000451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000451","line_url":"/filing/0000904454-13-000451#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; BLAIR JAMES C; TREU JESSE I; DP VI Associates, L.P.; VITULLO NICOLE; DOVEY BRIAN H","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":318.0,"shares_display":"318","price_per_share":5.28,"price_display":"5.28","price_state":"stated","total_value":1679.04,"total_display":"1,679.04","total_whole":"1,679","shares_owned_after":80820.0,"shares_owned_after_display":"80,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-15","filed_date":"2013-03-19","scope":"insider"},{"id":4275459,"accession":"0000904454-13-000441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000441","line_url":"/filing/0000904454-13-000441#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; TREU JESSE I; DP VI Associates, L.P.","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":166.0,"shares_display":"166","price_per_share":5.36,"price_display":"5.36","price_state":"stated","total_value":889.76,"total_display":"889.76","total_whole":"890","shares_owned_after":81138.0,"shares_owned_after_display":"81,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-14","filed_date":"2013-03-15","scope":"insider"},{"id":4275455,"accession":"0000904454-13-000441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000441","line_url":"/filing/0000904454-13-000441#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; TREU JESSE I; DP VI Associates, L.P.","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":256.0,"shares_display":"256","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":1382.4,"total_display":"1,382.40","total_whole":"1,382","shares_owned_after":81304.0,"shares_owned_after_display":"81,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-13","filed_date":"2013-03-15","scope":"insider"},{"id":5435119,"accession":"0000904454-13-000433","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000433","line_url":"/filing/0000904454-13-000433#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; VITULLO NICOLE; TREU JESSE I; BLAIR JAMES C; DOVEY BRIAN H; DP VI Associates, L.P.","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":210.0,"shares_display":"210","price_per_share":5.38,"price_display":"5.38","price_state":"stated","total_value":1129.8,"total_display":"1,129.80","total_whole":"1,130","shares_owned_after":81560.0,"shares_owned_after_display":"81,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-12","filed_date":"2013-03-13","scope":"insider"},{"id":5435116,"accession":"0000904454-13-000433","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000433","line_url":"/filing/0000904454-13-000433#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; VITULLO NICOLE; TREU JESSE I; BLAIR JAMES C; DOVEY BRIAN H; DP VI Associates, L.P.","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136.0,"shares_display":"136","price_per_share":5.34,"price_display":"5.34","price_state":"stated","total_value":726.24,"total_display":"726.24","total_whole":"726","shares_owned_after":81770.0,"shares_owned_after_display":"81,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-11","filed_date":"2013-03-13","scope":"insider"},{"id":4806854,"accession":"0000904454-13-000405","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000405","line_url":"/filing/0000904454-13-000405#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; TREU JESSE I; SCHOEMAKER KATHLEEN K; DP VI Associates, L.P.; DOVEY BRIAN H; BLAIR JAMES C","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":171.0,"shares_display":"171","price_per_share":5.32,"price_display":"5.32","price_state":"stated","total_value":909.72,"total_display":"909.72","total_whole":"910","shares_owned_after":81906.0,"shares_owned_after_display":"81,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-08","filed_date":"2013-03-11","scope":"insider"},{"id":4806847,"accession":"0000904454-13-000405","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000405","line_url":"/filing/0000904454-13-000405#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; TREU JESSE I; SCHOEMAKER KATHLEEN K; DP VI Associates, L.P.; DOVEY BRIAN H; BLAIR JAMES C","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":420.0,"shares_display":"420","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":2192.4,"total_display":"2,192.40","total_whole":"2,192","shares_owned_after":82077.0,"shares_owned_after_display":"82,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-07","filed_date":"2013-03-11","scope":"insider"},{"id":5239943,"accession":"0000904454-13-000393","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000393","line_url":"/filing/0000904454-13-000393#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; SCHOEMAKER KATHLEEN K; DP VI Associates, L.P.; DOVEY BRIAN H; TREU JESSE I; BLAIR JAMES C","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":127.0,"shares_display":"127","price_per_share":5.06,"price_display":"5.06","price_state":"stated","total_value":642.62,"total_display":"642.62","total_whole":"643","shares_owned_after":82497.0,"shares_owned_after_display":"82,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-06","filed_date":"2013-03-07","scope":"insider"},{"id":5239938,"accession":"0000904454-13-000393","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000393","line_url":"/filing/0000904454-13-000393#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; SCHOEMAKER KATHLEEN K; DP VI Associates, L.P.; DOVEY BRIAN H; TREU JESSE I; BLAIR JAMES C","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":134.0,"shares_display":"134","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":671.34,"total_display":"671.34","total_whole":"671","shares_owned_after":82624.0,"shares_owned_after_display":"82,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-05","filed_date":"2013-03-07","scope":"insider"},{"id":5275540,"accession":"0000904454-13-000378","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000378","line_url":"/filing/0000904454-13-000378#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; DP VI Associates, L.P.; BLAIR JAMES C; VITULLO NICOLE; TREU JESSE I","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":170.0,"shares_display":"170","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":851.7,"total_display":"851.70","total_whole":"852","shares_owned_after":82758.0,"shares_owned_after_display":"82,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-04","filed_date":"2013-03-05","scope":"insider"},{"id":5275536,"accession":"0000904454-13-000378","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000378","line_url":"/filing/0000904454-13-000378#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; DP VI Associates, L.P.; BLAIR JAMES C; VITULLO NICOLE; TREU JESSE I","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":253.0,"shares_display":"253","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":1267.53,"total_display":"1,267.53","total_whole":"1,268","shares_owned_after":82928.0,"shares_owned_after_display":"82,928","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-01","filed_date":"2013-03-05","scope":"insider"},{"id":4902300,"accession":"0000904454-13-000317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000317","line_url":"/filing/0000904454-13-000317#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; SCHOEMAKER KATHLEEN K; TREU JESSE I; BLAIR JAMES C; DOVEY BRIAN H; DP VI Associates, L.P.","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66.0,"shares_display":"66","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":330.66,"total_display":"330.66","total_whole":"331","shares_owned_after":83181.0,"shares_owned_after_display":"83,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-20","filed_date":"2013-02-22","scope":"insider"},{"id":4431035,"accession":"0000904454-13-000309","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000309","line_url":"/filing/0000904454-13-000309#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DP VI Associates, L.P.; SCHOEMAKER KATHLEEN K; TREU JESSE I; DOVEY BRIAN H; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":334.0,"shares_display":"334","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":1676.68,"total_display":"1,676.68","total_whole":"1,677","shares_owned_after":83247.0,"shares_owned_after_display":"83,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-19","filed_date":"2013-02-20","scope":"insider"},{"id":4431032,"accession":"0000904454-13-000309","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000309","line_url":"/filing/0000904454-13-000309#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DP VI Associates, L.P.; SCHOEMAKER KATHLEEN K; TREU JESSE I; DOVEY BRIAN H; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99.0,"shares_display":"99","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":495.0,"total_display":"495.00","total_whole":"495","shares_owned_after":83581.0,"shares_owned_after_display":"83,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-15","filed_date":"2013-02-20","scope":"insider"},{"id":4853684,"accession":"0000904454-13-000297","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000297","line_url":"/filing/0000904454-13-000297#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DP VI Associates, L.P.; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; TREU JESSE I; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98.0,"shares_display":"98","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":490.98,"total_display":"490.98","total_whole":"491","shares_owned_after":83680.0,"shares_owned_after_display":"83,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-14","filed_date":"2013-02-15","scope":"insider"},{"id":4853678,"accession":"0000904454-13-000297","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000297","line_url":"/filing/0000904454-13-000297#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DP VI Associates, L.P.; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; TREU JESSE I; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":191.0,"shares_display":"191","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":955.0,"total_display":"955.00","total_whole":"955","shares_owned_after":83778.0,"shares_owned_after_display":"83,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-13","filed_date":"2013-02-15","scope":"insider"},{"id":5552953,"accession":"0000904454-13-000161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000161","line_url":"/filing/0000904454-13-000161#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; SCHOEMAKER KATHLEEN K; BLAIR JAMES C; VITULLO NICOLE; DOVEY BRIAN H; DP VI Associates, L.P.","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":322.0,"shares_display":"322","price_per_share":4.85,"price_display":"4.85","price_state":"stated","total_value":1561.7,"total_display":"1,561.70","total_whole":"1,562","shares_owned_after":83969.0,"shares_owned_after_display":"83,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-01","filed_date":"2013-02-05","scope":"insider"},{"id":4515525,"accession":"0000904454-13-000150","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000150","line_url":"/filing/0000904454-13-000150#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; SCHOEMAKER KATHLEEN K; TREU JESSE I; DOVEY BRIAN H; DP VI Associates, L.P.; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":613.0,"shares_display":"613","price_per_share":4.71,"price_display":"4.71","price_state":"stated","total_value":2887.23,"total_display":"2,887.23","total_whole":"2,887","shares_owned_after":84291.0,"shares_owned_after_display":"84,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-31","filed_date":"2013-02-01","scope":"insider"},{"id":4515522,"accession":"0000904454-13-000150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000150","line_url":"/filing/0000904454-13-000150#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; SCHOEMAKER KATHLEEN K; TREU JESSE I; DOVEY BRIAN H; DP VI Associates, L.P.; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":367.0,"shares_display":"367","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":1835.0,"total_display":"1,835.00","total_whole":"1,835","shares_owned_after":84904.0,"shares_owned_after_display":"84,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-30","filed_date":"2013-02-01","scope":"insider"},{"id":5552951,"accession":"0000904454-13-000136","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000136","line_url":"/filing/0000904454-13-000136#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DP VI Associates, L.P.; TREU JESSE I; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":507.0,"shares_display":"507","price_per_share":5.27,"price_display":"5.27","price_state":"stated","total_value":2671.89,"total_display":"2,671.89","total_whole":"2,672","shares_owned_after":85271.0,"shares_owned_after_display":"85,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-29","filed_date":"2013-01-30","scope":"insider"},{"id":5552949,"accession":"0000904454-13-000136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000136","line_url":"/filing/0000904454-13-000136#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DP VI Associates, L.P.; TREU JESSE I; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":551.0,"shares_display":"551","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":2975.4,"total_display":"2,975.40","total_whole":"2,975","shares_owned_after":85778.0,"shares_owned_after_display":"85,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-28","filed_date":"2013-01-30","scope":"insider"},{"id":4713097,"accession":"0000904454-13-000132","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000132","line_url":"/filing/0000904454-13-000132#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DP VI Associates, L.P.; VITULLO NICOLE; TREU JESSE I; BLAIR JAMES C; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K","owner_display_name":"DP VI Associates, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":456.0,"shares_display":"456","price_per_share":5.38,"price_display":"5.38","price_state":"stated","total_value":2453.28,"total_display":"2,453.28","total_whole":"2,453","shares_owned_after":86329.0,"shares_owned_after_display":"86,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-25","filed_date":"2013-01-28","scope":"insider"},{"id":4713088,"accession":"0000904454-13-000132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000132","line_url":"/filing/0000904454-13-000132#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DP VI Associates, L.P.; VITULLO NICOLE; TREU JESSE I; BLAIR JAMES C; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K","owner_display_name":"DP VI Associates, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1201.0,"shares_display":"1,201","price_per_share":5.45,"price_display":"5.45","price_state":"stated","total_value":6545.45,"total_display":"6,545.45","total_whole":"6,545","shares_owned_after":86785.0,"shares_owned_after_display":"86,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-24","filed_date":"2013-01-28","scope":"insider"},{"id":4431006,"accession":"0000904454-13-000086","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000086","line_url":"/filing/0000904454-13-000086#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DP VI Associates, L.P.; DOVEY BRIAN H; TREU JESSE I; BLAIR JAMES C; VITULLO NICOLE; SCHOEMAKER KATHLEEN K","owner_display_name":"DP VI Associates, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":839.0,"shares_display":"839","price_per_share":5.11,"price_display":"5.11","price_state":"stated","total_value":4287.29,"total_display":"4,287.29","total_whole":"4,287","shares_owned_after":87986.0,"shares_owned_after_display":"87,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-23","filed_date":"2013-01-24","scope":"insider"},{"id":4431002,"accession":"0000904454-13-000086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000086","line_url":"/filing/0000904454-13-000086#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DP VI Associates, L.P.; DOVEY BRIAN H; TREU JESSE I; BLAIR JAMES C; VITULLO NICOLE; SCHOEMAKER KATHLEEN K","owner_display_name":"DP VI Associates, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":495.0,"shares_display":"495","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":2484.9,"total_display":"2,484.90","total_whole":"2,485","shares_owned_after":88825.0,"shares_owned_after_display":"88,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-22","filed_date":"2013-01-24","scope":"insider"},{"id":5435088,"accession":"0000904454-13-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000064","line_url":"/filing/0000904454-13-000064#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; VITULLO NICOLE; BLAIR JAMES C; DP VI Associates, L.P.; DOVEY BRIAN H; TREU JESSE I","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":631.0,"shares_display":"631","price_per_share":5.19,"price_display":"5.19","price_state":"stated","total_value":3274.89,"total_display":"3,274.89","total_whole":"3,275","shares_owned_after":89320.0,"shares_owned_after_display":"89,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-18","filed_date":"2013-01-22","scope":"insider"},{"id":5435085,"accession":"0000904454-13-000064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000064","line_url":"/filing/0000904454-13-000064#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; VITULLO NICOLE; BLAIR JAMES C; DP VI Associates, L.P.; DOVEY BRIAN H; TREU JESSE I","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":418.0,"shares_display":"418","price_per_share":5.35,"price_display":"5.35","price_state":"stated","total_value":2236.3,"total_display":"2,236.30","total_whole":"2,236","shares_owned_after":89951.0,"shares_owned_after_display":"89,951","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-17","filed_date":"2013-01-22","scope":"insider"},{"id":8916462,"accession":"0000904454-11-000271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-11-000271","line_url":"/filing/0000904454-11-000271#line-1","is_derivative":false,"issuer_cik":"0001267602","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001267602","owner_cik":"0001298034","owner_name":"DP VI Associates, L.P.","owner_display_name":"DP VI Associates, L.P.","owner_url":"/insider/0001298034","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6914.0,"shares_display":"6,914","price_per_share":8.04,"price_display":"8.04","price_state":"stated","total_value":55588.56,"total_display":"55,588.56","total_whole":"55,589","shares_owned_after":40790.0,"shares_owned_after_display":"40,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-02","filed_date":"2011-06-03","scope":"insider"},{"id":5020028,"accession":"0000904454-06-000945","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-06-000945","line_url":"/filing/0000904454-06-000945#line-1","is_derivative":false,"issuer_cik":"0001298034","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001298034","owner_cik":"0001298034","owner_name":"DP VI Associates, L.P.","owner_display_name":"DP VI Associates, L.P.","owner_url":"/insider/0001298034","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6459.0,"shares_display":"6,459","price_per_share":13.52,"price_display":"13.52","price_state":"stated","total_value":87325.68,"total_display":"87,325.68","total_whole":"87,326","shares_owned_after":19379.0,"shares_owned_after_display":"19,379","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-21","filed_date":"2006-12-22","scope":"insider"},{"id":3582978,"accession":"0000904454-06-000915","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-06-000915","line_url":"/filing/0000904454-06-000915#line-1","is_derivative":false,"issuer_cik":"0001298034","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001298034","owner_cik":"0001298034","owner_name":"DP VI Associates, L.P.","owner_display_name":"DP VI Associates, L.P.","owner_url":"/insider/0001298034","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12900.0,"shares_display":"12,900","price_per_share":25.62,"price_display":"25.62","price_state":"stated","total_value":330498.0,"total_display":"330,498.00","total_whole":"330,498","shares_owned_after":21068.0,"shares_owned_after_display":"21,068","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-12","filed_date":"2006-12-13","scope":"insider"},{"id":3631866,"accession":"0000904454-06-000607","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-06-000607","line_url":"/filing/0000904454-06-000607#line-1","is_derivative":false,"issuer_cik":"0001298034","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001298034","owner_cik":"0001298034","owner_name":"DP VI Associates, L.P.","owner_display_name":"DP VI Associates, L.P.","owner_url":"/insider/0001298034","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6459.0,"shares_display":"6,459","price_per_share":13.03,"price_display":"13.03","price_state":"stated","total_value":84160.77,"total_display":"84,160.77","total_whole":"84,161","shares_owned_after":25838.0,"shares_owned_after_display":"25,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-09-18","filed_date":"2006-09-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001348649","name":"CoLucid Pharmaceuticals, Inc.","url":"/issuer/0001348649","role":"Ten percent owner","n_filings":2,"first_seen":"2016-05-02","last_seen":"2016-08-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001267602","name":"ALIMERA SCIENCES INC","url":"/issuer/0001267602","role":"Ten percent owner","n_filings":7,"first_seen":"2011-06-03","last_seen":"2014-01-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001333248","name":"CADENCE PHARMACEUTICALS INC","url":"/issuer/0001333248","role":"Ten percent owner","n_filings":17,"first_seen":"2013-01-22","last_seen":"2013-03-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001339455","name":"Somaxon Pharmaceuticals, Inc.","url":"/issuer/0001339455","role":"Ten percent owner","n_filings":2,"first_seen":"2006-09-20","last_seen":"2006-12-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001347178","name":"Vanda Pharmaceuticals Inc.","url":"/issuer/0001347178","role":"Ten percent owner","n_filings":1,"first_seen":"2006-12-13","last_seen":"2006-12-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001298034","retrieved_at":"2026-08-23T14:36:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}